Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Japanese researchers patent novel ACC inhibitors

May 24, 2013

Researchers at Merck & Co. present novel CETP inhibitors

May 24, 2013

Gene replacement therapy demonstrates good safety in patients with Pompe's disease

May 24, 2013

Roche presents novel GPBAR1 agonists for diabetes

May 23, 2013

Recombinant LCAT replacement therapy mobilizes excess cholesterol from tissue in vivo

May 22, 2013

AbbVie initiates phase III renal outcomes study of atrasentan in diabetic nephropathy

May 22, 2013

Sanofi divulges novel PKC-beta 2 inhibitors

May 21, 2013

Breakthrough therapy designation for Synageva's sebelipase alfa

May 21, 2013

Bydureon launched in Japan

May 21, 2013

FDA clears Oramed's IND to test ORMD-0801 oral insulin

May 21, 2013

Popular Stories

Today's news in brief
BioWorld
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...